In children and adolescents, data remain limited and fragmented, with studies varying in population characteristics, diagnostic criteria, and reported outcomes, and some relying on older cohorts from eras when insulin therapy and diabetes management were not comparable to current standards. This evidence concerns the gene INS and diabetes mellitus.